These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
30. Feline acute intermittent porphyria: a phenocopy masquerading as an erythropoietic porphyria due to dominant and recessive hydroxymethylbilane synthase mutations. Clavero S; Bishop DF; Haskins ME; Giger U; Kauppinen R; Desnick RJ Hum Mol Genet; 2010 Feb; 19(4):584-96. PubMed ID: 19934113 [TBL] [Abstract][Full Text] [Related]
31. How I treat erythropoietic protoporphyria and X-linked protoporphyria. Leaf RK; Dickey AK Blood; 2023 Jun; 141(24):2921-2931. PubMed ID: 36898083 [TBL] [Abstract][Full Text] [Related]
32. Phase I open label liver-directed gene therapy clinical trial for acute intermittent porphyria. D'Avola D; López-Franco E; Sangro B; Pañeda A; Grossios N; Gil-Farina I; Benito A; Twisk J; Paz M; Ruiz J; Schmidt M; Petry H; Harper P; de Salamanca RE; Fontanellas A; Prieto J; González-Aseguinolaza G J Hepatol; 2016 Oct; 65(4):776-783. PubMed ID: 27212246 [TBL] [Abstract][Full Text] [Related]
33. Mechanistic modelling of enzyme-restoration effects of new recombinant liver-targeted proteins in acute intermittent porphyria. Vera-Yunca D; Córdoba KM; Parra-Guillen ZP; Jericó D; Fontanellas A; Trocóniz IF Br J Pharmacol; 2022 Jul; 179(14):3815-3830. PubMed ID: 35170015 [TBL] [Abstract][Full Text] [Related]
34. AGA Clinical Practice Update on Diagnosis and Management of Acute Hepatic Porphyrias: Expert Review. Wang B; Bonkovsky HL; Lim JK; Balwani M Gastroenterology; 2023 Mar; 164(3):484-491. PubMed ID: 36642627 [TBL] [Abstract][Full Text] [Related]
35. Pathogenesis and clinical features of the acute hepatic porphyrias (AHPs). Bonkovsky HL; Dixon N; Rudnick S Mol Genet Metab; 2019 Nov; 128(3):213-218. PubMed ID: 30987916 [TBL] [Abstract][Full Text] [Related]
36. Hematologic aspects of the porphyrias. Sassa S Int J Hematol; 2000 Jan; 71(1):1-17. PubMed ID: 10729988 [TBL] [Abstract][Full Text] [Related]
37. Ursodesoxycholic acid and heme-arginate are unable to improve hematopoiesis and liver injury in an erythropoietic protoporphyria mouse model. Abitbol M; Puy H; Sabaté JM; Guénet JL; Deybach JC; Montagutelli X Physiol Res; 2006; 55 Suppl 2():S93-101. PubMed ID: 17298226 [TBL] [Abstract][Full Text] [Related]
38. A family with acute intermittent porphyria. Billoo AG; Lone SW J Coll Physicians Surg Pak; 2008 May; 18(5):316-8. PubMed ID: 18541093 [TBL] [Abstract][Full Text] [Related]
39. Understanding Carbohydrate Metabolism and Insulin Resistance in Acute Intermittent Porphyria. Solares I; Jericó D; Córdoba KM; Morales-Conejo M; Ena J; Enríquez de Salamanca R; Fontanellas A Int J Mol Sci; 2022 Dec; 24(1):. PubMed ID: 36613492 [TBL] [Abstract][Full Text] [Related]